文献速递临床试验与 GCP流行病学与生物统计

低果糖和/或低蔗糖饮食降低胰岛素抵抗的有效性(DISFRUTE研究):随机对照试验研究方案

Effectiveness of a low-fructose and/or low-sucrose diet in decreasing insulin resistance (DISFRUTE study): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-08-07

本研究为在初级保健中心开展的实地随机对照试验,拟纳入29至66岁、BMI 29至40.99 kg/m2且无糖尿病的成人,比较由医生或护士监督的低果糖和/或低蔗糖饮食与标准饮食对胰岛素抵抗(HOMA2-IR)的影响。目前已随机分配245例至低果糖饮食干预组、245例至标准饮食对照组,主要终点为基线至第24周HOMA2-IR变化,第48周进行二次评估。

要点

  • 低果糖饮食通过计算标准饮食中游离及总果糖含量、去除果糖含量最高四分位数的食物来设计。
  • 两组均处方比参与者能量需求低30%至40%的饮食。
  • 主要终点为基线至第24周HOMA2-IR变化,次要终点为第24周至第48周HOMA2-IR变化及相关代谢指标。

核心结论

  • 若所测试的低果糖/蔗糖饮食能够降低胰岛素抵抗,结果若转化为常规临床实践,可能提供迄今尚不可用的预防2型糖尿病的工具。

研究设计与样本

  • 本研究为在初级保健中心开展的实地随机对照试验。
  • 参与者为29至66岁、BMI 29至40.99 kg/m2且无糖尿病的成人。
  • 目前已随机分配245例至低果糖饮食干预组(位于特内里费岛西部卫生服务区健康中心),245例至标准饮食对照组(位于东部卫生服务区健康中心)。
  • 招募为机会性招募,由参与健康中心的医生和护士实施。
  • 干预组接受低果糖饮食,两组均处方比参与者能量需求低30%至40%的饮食。

主要发现

  • 在基线及干预24周后记录饮食记录、体力活动、腰围、BMI、血压、空腹血糖和胰岛素浓度(HOMA2-IR)及血脂谱;并在75克葡萄糖负荷后2小时记录血糖、胰岛素及血脂谱。
  • 48周后(干预结束后24周)再次获取空腹血样并进行体格检查,重复所有检测和测量,但饮食记录、体力活动和口服葡萄糖负荷除外。
  • 主要终点为基线至第24周HOMA2-IR变化;其他结局为HDL胆固醇、LDL胆固醇、甘油三酯、腰围身高比和BMI的变化。
  • 次要终点为第24周至第48周HOMA2-IR变化及上述结局。
  • 组间比较采用非配对变量的Student t检验或分布非正态时的Mann-Whitney U检验;多变量回归模型将用于控制研究设计未考虑的混杂因素及独立预后因素。

关键数值与推荐

  • 低果糖饮食通过计算标准饮食中游离和总(游离+与蔗糖结合的果糖)果糖含量,并去除果糖含量处于最高四分位数的食物(按标准饮食中的量)来设计。
  • 两组均处方比参与者能量需求低30%至40%的饮食。
  • 主要终点为基线至第24周HOMA2-IR变化。
  • 次要终点为第24周至第48周HOMA2-IR变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Research published to date on the relationship between insulin resistance (IR) and fructose consumption is scarce, has used different methods, and has yielded sometimes contradictory results. This study aims to determine whether a low-fructose and/or low-sucrose diet supervised by a physician or nurse decreases IR compared to a standard diet. METHODS/DESIGN: This field trial is located at primary care centers. The participants are adults aged 29 to 66 years, with a Body mass Index (BMI) between 29 and 40.99 kg/m2 and without diabetes. To date, 245 participants have been assigned randomly to the low-fructose diet intervention group (LFDI) at health centers in the western health service zone of Tenerife island, and 245 to the standard-diet control group (SDC) at health centers in the eastern health service zone. Recruitment is opportunistic and is carried out by physicians and nurses at participating health centers. Initially (baseline), and after 24 weeks of intervention, dietary records, physical activity, waist circumference, BMI, blood pressure, fasting blood glucose and insulin concentrations (HOMA2-IR) and lipid profile are recorded; blood glucose and insulin and lipid profile are also recorded 2 h after a 75-g glucose overload. After 48 weeks (24 weeks after the intervention), fasting blood samples are again obtained and a physical examination is performed. All tests and measures are repeated and recorded except dietary records, physical activity and oral glucose overload. Low-fructose diets are designed by calculating free and total (free + fructose associated with sucrose) fructose contents in standard diets, and removing foods with a fructose content in the highest quartile for the amounts in the standard diet. Participants in both groups are prescribed a diet that contains 30 to 40% less than the participant's energy requirements. The primary endpoint is change in HOMA2-IR between baseline and week 24, and other outcomes are change in HDL-cholesterol, LDL-cholesterol, triglycerides , waist circumference to height ratio and BMI. The secondary endpoint is change in HOMA2-IR between week 24 and week 48 together with the outcomes noted above. Comparisons between groups for variables used to indicate IR levels are done with a Student's t test for unpaired variables or the Mann-Whitney U test if the distribution is not normal. Multivariate regression models will be used to control for confounding factors not accounted for in the study design, and for independent prognostic factors. DISCUSSION: If the dietary intervention being tested, i.e., a diet low in fructose/sucrose, is able to reduce IR, the results - if translated into regular clinical practice - could provide a hitherto unavailable tool to prevent type-2 diabetes mellitus. TRIAL REGISTRATION: ISRCTN, ID: ISRCTN41579277 . Registered retrospectively on 15 November 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Domínguez Coello S, Carrillo Fernández L, Gobierno Hernández J, et al. Effectiveness of a low-fructose and/or low-sucrose diet in decreasing insulin resistance (DISFRUTE study): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28784181. doi:10.1186/s13063-017-2043-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。